Try our Advanced Search for more refined results
Purdue Pharma L.P.
Case Number:
7:19-bk-23649
Court:
Nature of Suit:
Firms
- Brown & Connery
- Tarter Krinsky
- Teitelbaum Law Group
- Duane Morris
- Hagens Berman
- Simmons Hanly
- Caplin & Drysdale
- Motley Rice
- Debevoise & Plimpton
- Bielli & Klauder
- Godfrey & Kahn
- Himes Petrarca
- Manatt Phelps
- Wachtell Lipton
- Hurwitz Fine
- Morris Nichols
- Gilbert LLP
- BatesCarey
- Lowe Stein
- Arnold & Porter
- Archer & Greiner
- Katsky Korins
- Brown Rudnick
- Gage Spencer & Fleming
- Pashman Stein
- Hogan Lovells
- Katten Muchin
- Morrison & Foerster
- Doshi Legal Group
- Willkie Farr
- Buchalter LLP
- FBT Gibbons
- Terrell Hogan
- Troutman
- Goodwin Procter
- Davis Polk
- Foley & Lardner
- Pillsbury Winthrop
- ArentFox Schiff
- Phillips Lytle
- Dentons
- HSF Kramer
- Ice Miller
- Crowell & Moring
- Morgan Lewis
- Reed Smith
- McDermott Will & Schulte
- Gertz & Rosen
- Consovoy McCarthy
- Porteous Hainkel
- Jones Day
- Porter Hedges
- Kirkland & Ellis
- Bentley & Bruning
- ASK LLP
- Joseph Hage
- Doster Ullom
- Marino Tortorella
- White & Case
- Boies Schiller
- Spangenberg Shibley
- Cuneo Gilbert
- MoloLamken
- Mintz Levin
- WestLoop Law
- Miller Nash LLP
- Cronin Fried
- Loeb & Loeb
- Diamond McCarthy
- Slevin & Hart
- Plevin & Turner
- Schenck Price
- Bialson Bergen
- Martin S. Rapaport
- Skadden Arps
- Akerman LLP
- Fox Swibel
- Lerner Arnold
- Burke Warren
- Shook Hardy
- Sherrard Roe
- Taft Stettinius
- Sahn Ward
- Cleary Gottlieb
- Simpson Thacher & Bartlett
- Napoli Shkolnik
- D. Miller & Associates
- McGrail & Bensinger
- Marcus & Shapira
- Quinn Emanuel
- Pachulski Stang
- King & Spalding
- UB Greensfelder
- Wilk Auslander
- Stevens & Lee
- Faegre Drinker
- Shafferman & Feldman
- Squire Patton
- Blitman & King
- Hughes Socol
- Robins Kaplan
- WilmerHale
- Blank Rome
- Keller Rohrback
- Kobre & Kim
- Ballard Spahr
- O'Melveny & Myers
- Keller Postman
- Webb Law Firm
- Kleinberg Kaplan
- Clifford Law Offices
- Barack Ferrazzano
- Stutzman Bromberg
- Levenfeld Pearlstein
- Rothstein Mandell
- Seyfarth Shaw
- MacElree Harvey
- Klehr Harrison
- Pullman & Comley
- Mehri & Skalet
- Tate Law Group LLC
- Lowey Dannenberg
- Williams Mullen
- Waldrep Wall
- Barclay Damon
- Dechert LLP
- Ifrah Law
- Seward & Kissel
- Calfee Halter
- White Coleman & Associates
- Miller Shah
- Susman Godfrey
- O'Brien Belland
- Binder & Schwartz
- Alston & Bird
- Akin Gump
- Carter Ledyard
- Shipman & Goodwin
- McElroy Deutsch
- Henrichsen Law Group
- Jenner & Block
- Haug Partners
- Hobbs Straus
- Latham & Watkins
- Mayer Brown
- Milbank LLP
Companies
- Teamsters Local 456
- Henry Schein Inc.
- Cencora Inc.
- Bristol-Myers Squibb Co.
- Hikma Pharmaceuticals PLC
- Giant Eagle Inc.
- McKesson Corp.
- BDO LLP
- Otis Worldwide Corp.
- Johnson & Johnson
- Liberty Mutual Insurance Group
- FTI Consulting Inc.
- Kodiak Area Native Association
- Ranbaxy
- PRA Health Sciences Inc.
- Ascent Pharmaceuticals Inc.
- Blue Cross Blue Shield Association
- Aleutian Pribilof Islands Association Inc.
- KVK Tech Inc.
- Collegium Pharmaceutical Inc.
- Noramco Inc.
- Endo International PLC
- Impax Laboratories, Inc.
- Omnicare Inc.
- Bausch Health Cos. Inc.
- Province LLC
- Sandoz International GmbH
- Avrio Health LP
- Nardello & Co. LLC
- DuPont de Nemours Inc.
- Hain Capital Group LLC
- United Parcel Service Inc.
- Express Scripts Holding Co.
- CVS Health Corp.
- Ironshore Inc.
- Amneal Pharmaceuticals Inc.
- Sun Pharmaceutical Industries Ltd.
- Loblaw Cos.
- Tucson Medical Center
- TR Capital Management LLC
- Viatris Inc.
- The Cigna Group
- Alaska Native Tribal Health Consortium
- Anda Inc.
- Walmart Inc.
- AXA XL Ltd.
- Allergan PLC
- BDO USA LLP
- Rubris Inc.
- AlixPartners LLP
- Purdue Pharma LP
- United Food & Commercial Workers International Union
- ASM Capital LP
- SAP AG
- Apria Healthcare Group
- Cardinal Health Inc.
- Arcadia Consumer Healthcare
- International Union Of Operating Engineers
- Old Republic Insurance Co.
- Oracle Corp.
- Thermo Fisher Scientific Inc.
- Verita Global LLC
- Houlihan Lokey Inc.
- American Federation of Labor & Congress of Industrial Organizations
- Jefferies Financial Group Inc.
- Teva Pharmaceutical Industries Ltd.
Government Agencies
- Pension Benefit Guaranty Corp.
- Missouri Department of Revenue
- U.S. District Court for the District of Columbia
- Tennessee Attorney General's Office
- Pala Band of Mission Indians
- Seldovia Village Tribe
- Nez Perce Tribe
- Town of Ramapo, New York
- Jamestown S'Klallam Tribe
- St. Regis Mohawk Tribe
- State of Indiana
- City of Bayonne, New Jersey
- Washington State Department of Revenue
- Colorado Attorney General's Office
- Port Gamble S'Klallam Tribe
- Borough of Paramus, New Jersey
- State of Nevada
- Northwestern Band of the Shoshone Nation
- Town of Babylon, New York
- Town of Brookhaven, New York
- New York Department of Financial Services
- Town of Hempstead, New York
- Commonwealth of Massachusetts
- Hopi Tribe
- Suquamish Tribe
- Ohio Attorney General's Office
Sectors & Industries:
-
September 17, 2020
Purdue Wants Opioid Suit Ch. 11 Shield Extended To March
Purdue Pharma LP is asking a New York bankruptcy court to extend the injunction blocking thousands of suits against it over its role in the opioid crisis until March, saying that allowing the stay to expire in October would scuttle the progress it's made in its reorganization efforts.
-
August 26, 2020
NAACP To Get Its Say On Purdue Ch. 11 Opioid Settlement
Purdue Pharma told a New York bankruptcy judge Wednesday that the NAACP will get its seat at the table in the mediation to determine how the assets of the bankrupt drugmaker will be distributed to victims of the opioid crisis.
-
August 18, 2020
Purdue And Sacklers Caused $2.16T In Damage, NY Says
New York and 48 other states on Monday told a bankruptcy court that Purdue Pharma LP and its former owners the Sackler family have caused almost $2.16 trillion in damage to the U.S. after two decades of pushing opioids.
-
August 07, 2020
NAACP Wants Seat At Table In Purdue Bankruptcy Case
The NAACP on Friday asked a New York bankruptcy judge for a seat at the table in the Purdue Pharma Chapter 11, saying it needs to ensure a fair share of the proceeds of the case's opioid settlement goes to communities of color.
-
July 23, 2020
Judge To Wait On Claim Talks Result For Purdue Class Call
A New York bankruptcy judge Thursday agreed to adjourn a request to allow five new classes of alleged opioid victims to file claims in Purdue Pharma's Chapter 11 until after claim mediation ends, saying an agreement there would mean he wouldn't have to rule.
-
July 16, 2020
Purdue Asks Court To Say No To New Classes In Ch. 11 Case
Purdue Pharma asked a New York bankruptcy judge Thursday to reject requests to allow five claims by classes of alleged opioid victims in its Chapter 11 case, saying adding new classes would be an unnecessary, last-minute complication.
-
June 23, 2020
Purdue Gets OK For $6.5M Investment In Overdose Drug
A New York bankruptcy judge gave Purdue Pharma permission Tuesday to invest $6.5 million in a company working on an over-the-counter opioid-overdose drug, saying that keeping the development effort going was an appropriate use of the opioid-maker's money.
-
June 23, 2020
Purdue Wants Sackler Claims To Stay Blocked By Ch. 11
Purdue Pharma LP is asking a New York federal judge not to overturn an order keeping creditors from going after its former president, saying the judge overseeing its Chapter 11 case was right to rule that the claims would disrupt its reorganization.
-
June 03, 2020
Purdue's Ch. 11 Claim Deadline Bumped 30 Days For Virus
A New York bankruptcy judge Wednesday granted Purdue Pharma's COVID-19-inspired request to give its creditors an extra month to file their Chapter 11 claims against the company, rejecting calls for more time and no extension by two sets of states.
-
May 20, 2020
States Join Bid For Virus Delay In Purdue Pharma Bankruptcy
Two dozen states and the District of Columbia have joined calls for a New York federal court to push back the cutoff date for filing claims in the bankruptcy of Purdue Pharma LP, citing the obstacles created by the ongoing COVID-19 pandemic.